Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics

Journal: Science

Published: 2018-01-12

DOI: 10.1126/science.aan4472

Affiliations: 14

Authors: 44

Go to article
Institutions FC
School of Medicine (SOM), UC San Diego, United States of America (USA) 0.33
GlaxoSmithKline Spain, Spain 0.11
Harvard Department of Immunology and Infectious Diseases, United States of America (USA) 0.09
Department of Microbiology and Immunology, CU, United States of America (USA) 0.07
Vagelos College of Physicians and Surgeons (P&S), CU, United States of America (USA) 0.07
Department of Biochemistry and Molecular Biology (BMB), Penn State, United States of America (USA) 0.07
Genomics Institute of the Novartis Research Foundation (GNF), United States of America (USA) 0.07
Sanger Institute Malaria Programme, United Kingdom (UK) 0.05
Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS), UC San Diego, United States of America (USA) 0.03
John T. Milliken Department of Medicine, WUSTL, United States of America (USA) 0.02
Department of Molecular Microbiology, WUSTL, United States of America (USA) 0.02
Infectious Disease and Microbiome Program, Broad Institute, United States of America (USA) 0.02
Medicines for Malaria Venture (MMV), Switzerland 0.02
Division of Infectious Diseases, CU, United States of America (USA) 0.01

Return